A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...
Drug sold under brand names Ozempic and Wegovy appears to stop people hankering after other addictive substances ...
The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.